再次肾脏移植临床管理及疗效分析——附17例分析

doi:10.3969/j.issn.1005-6483.2020.11.003

摘要/Abstract

摘要： 目的：探讨再次肾移植病人临床管理策略及其临床疗效。方法：依据解放军总医院第八医学中心和北大国际医院制订的再次肾移植临床管理策略对2017年6月～2019年6月共17例再次肾移植病人规范性管理，均选择公民逝世后器官捐献(DCD)供肾移植，观察术后急性排斥反应(AR)、移植肾功能延迟恢复(DGF)、肺部感染等临床指标。结果：二次移植14例(82.4%)，三次移植3例(17.6%)；移植肾切除5例(29.4%)，移植肾保留12例(70.6%)；预存抗体阳性脱敏5例(29.4%)，抗体阴性非脱敏12例(70.6%)。AR共4例(23.5%)，肺部感染共6例(35.3%)，DGF共1例(5.9%)。移植肾切除组AR 1例(20%)肺部感染1例(20%)；移植肾保留组AR 3例(25%)，肺部感染5例(41.7%)。脱敏组AR 1例(20%)，肺部2例(40%)；非脱敏组AR 3例(25%)肺部感染4例(33.3%)。中位随访时间14.5个月(6～36个月)，1年人肾存活率94.1%，1例(5.9%)死亡。结论：合理规范的临床管理策略可使再次肾脏移植获得较好的临床效果。不切除失功的移植肾病人肺部感染机率明显高于移植肾切除病人。脱敏治疗可以明显降低再次肾脏移植的排斥风险，且不会明显增加感染机会。

关键词: 再次肾脏移植, 急性排斥反应, 肺部感染

Abstract: Objective：To investigate the clinical management strategy and clinical outcomes of kidney retransplantation.Methods：According to the clinical management strategies of kidney retransplantation of the eighth medical center of PLA General Hospital and Peking University International Hospital,a total of 17 patients who took kidney retransplantation from donation after citizen death(DCD) in both hospitals from June 2017 to June 2019 were managed in the formulated standardized strategies.The clinical outcomes such as acute rejection(AR),delayed graft function(DGF),pulmonary infection were observed.Results：14 cases(82.4%) were second kidney transplantation and 3 cases(17.6%) were three times transplantation;5 cases(29.4%) with nephrectomy and 12 cases(70.6%) with the previous kidney graft preserved;5 cases(29.4%) endured desensitization because of population reactive antibody positive and 12 cases(70.6%) were negative.There were 4 cases of AR(23.5%),6 cases of pulmonary infection(35.3%) and 1 case of DGF(5.9%).There were 1 case(20%) of AR in the nephrectomy group,1 case(20%) of pulmonary infection;3 cases(25%) of AR and 5 cases(41.7%) of lung infection in the transplantation group.In desensitization group,there were 1 case of AR(20%),2 cases of lung(40%),3 cases of AR(25%) and 4 cases of pulmonary infection(33.3%) in nondesensitization group.Median follow-up time was 14.5 months (636 months).The 1year renal survival rate was 94.1%(16/17 cases) and 1 case(5.9%) died.Conclusion：Although kidney retransplantation recipients were in immunologically high risk,reasonable and standardized clinical management strategy can achieve better clinical outcomes.There are significantly the risk of pulmonary infection after renal transplantation in patients without nephrectomy.Desensitization therapy could significantly reduce the risk of rejection after renal transplantation,and did not significantly increase the risk of infection.

Key words: kidney retransplantation, 〓acute rejection, 〓pulmonary infection

闫晓冬, 石炳毅, 徐俊楠等. 再次肾脏移植临床管理及疗效分析——附17例分析[J]. 临床外科杂志, 2020, 28(11): 1007-1011.

参考文献

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

本文评价

推荐阅读 10

[1]	马跃峰邢鑫马震川孔冉冉孙良璋乔哲李少民. 术中肋间神经阻滞联合术后静脉使用镇痛泵对开胸术后镇痛效果的观察[J]. 临床外科杂志, 2018, 26(9): 686 -688 .
[2]	许万紫曹海龙王东进. 经左胸后外侧切口进行非体外循环下二次冠状动脉旁路移植术的临床运用[J]. 临床外科杂志, 2018, 26(11): 842 -844 .
[3]	雷霆. 再谈神经外科重症监护亚专业的规范化建设[J]. 临床外科杂志, 2020, 28(10): 901 -902 .
[4]	王宁. 神经外科重症医学从理论到实践的飞跃[J]. 临床外科杂志, 2020, 28(10): 903 -904 .
[5]	王勇陶治鹤田少斌. 手术与放疗间隔与新发胶质母细胞瘤病人肿瘤增长及预后的相关性[J]. 临床外科杂志, 2020, 28(10): 934 -937 .
[6]	张和栋, 彭龙开, 谢续标. 中美人体器官移植医师培训比较[J]. 临床外科杂志, 2020, 28(11): 1000 -1002 .
[7]	沈辉, 张扬, 陈海泉. ⅢA期非小细胞肺癌以外科为基础的多学科治疗[J]. 临床外科杂志, 2020, 28(11): 1003 -1006 .
[8]	郑智, 查正彪, 刘纯等. 合并迷走右锁骨下动脉B型主动脉夹层个体化腔内治疗[J]. 临床外科杂志, 2020, 28(11): 1012 -1015 .
[9]	付亮, 赵金龙, 倪寅凯等. 经股静脉单纯食道超声引导下房间隔缺损封堵的近中期疗效[J]. 临床外科杂志, 2020, 28(11): 1016 -14018 .
[10]	焦逢春, 岳凯涛, 李娟. 新生儿气胸临床特点分析与救治策略[J]. 临床外科杂志, 2020, 28(11): 1018 -1019 .